Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia

Autor: Schaik, F.D.M. van, Mooiweer, E., Have, M. van der, Belderbos, T.D.G., Kate, F.J.W. ten, Offerhaus, G.J.A., Schipper, M.E.I., Dijkstra, G., Pierik, M., Stokkers, P.C.F., Ponsioen, C., Jong, D.J. de, Hommes, D.W., Bodegraven, A.A. van, Siersema, P.D., Oijen, M.G.H. van, Oldenburg, B., Dutch Initiative Crohn Colitis ICC
Přispěvatelé: Interne Geneeskunde, RS: NUTRIM - R2 - Gut-liver homeostasis, Gastroenterology and hepatology, CCA - Innovative therapy, Other departments, Pathology, Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, Oncology, Public Health, Gastroenterology & Hepatology, Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Translational Immunology Groningen (TRIGR), Groningen Institute for Organ Transplantation (GIOT)
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Male
POLYPS
endocrine system diseases
Colorectal cancer
medicine.medical_treatment
Kaplan-Meier Estimate
Inflammatory bowel disease
Gastroenterology
COLORECTAL-CANCER
Immunology and Allergy
POLYPECTOMY
Middle Aged
adenoma
Female
Colorectal Neoplasms
Adult
Risk
DYSPLASTIC LESIONS
medicine.medical_specialty
Adenoma
CARCINOMA
CHRONIC ULCERATIVE-COLITIS
colorectal cancer
Molecular gastro-enterology and hepatology Pathogenesis and modulation of inflammation [IGMD 2]
digestive system
dysplasia
inflammatory bowel disease
Internal medicine
SURVEILLANCE
Carcinoma
medicine
Humans
Molecular gastro-enterology and hepatology [IGMD 2]
Proportional Hazards Models
Retrospective Studies
Proportional hazards model
business.industry
Retrospective cohort study
ENDOSCOPIC RESECTION
medicine.disease
Inflammatory Bowel Diseases
Polypectomy
digestive system diseases
stomatognathic diseases
Dysplasia
ADEQUATE TREATMENT
Neoplasm Grading
business
FOLLOW-UP
Precancerous Conditions
Follow-Up Studies
Zdroj: Inflammatory Bowel Diseases, 19(2), 342-349. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 19(2), 342-349
Inflammatory Bowel Diseases, 19(2), 342-349. John Wiley and Sons Inc.
Inflammatory bowel diseases, 19(2), 342-349. John Wiley and Sons Inc.
van Schaik, F D M, Mooiweer, E, ten Have, M, Belderbos, T D G, Ten Kate, F J W, Offerhaus, G J A, Schipper, M E I, Dijkstra, G, Pierik, M, Stokkers, P C F, Ponsioen, C, de Jong, D J, Hommes, D W, van Bodegraven, A A, Siersema, P D, van Oijen, M G H & Oldenburg, B 2013, ' Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia ', Inflammatory Bowel Diseases, vol. 19, no. 2, pp. 342-349 . https://doi.org/10.1097/MIB.0b013e318286f771
Inflammatory Bowel Diseases, 19, 342-349
Inflammatory Bowel Diseases, 19, 2, pp. 342-349
Inflammatory Bowel Diseases, 19(2), 342-349. Oxford University Press
ISSN: 1078-0998
DOI: 10.1097/MIB.0b013e318286f771
Popis: Background: It is still unclear whether inflammatory bowel disease (IBD) patients with adenomas have a higher risk of developing high-grade dysplasia (HGD) or colorectal cancer (CRC) than non-IBD patients with sporadic adenomas. We compared the risk of advanced neoplasia (AN, defined as HGD or CRC) in IBD patients with adenomas to IBD patients without adenomas and patients without IBD with adenomas.Methods: IBD patients with a histological adenoma diagnosis (IBD + adenoma), age-matched IBD patients without adenoma (IBD-nonadenoma), and adenoma patients without IBD (nonIBD + adenoma) were enrolled in this study. Medical charts were reviewed for adenoma characteristics and development of AN. The endoscopic appearance of the adenomas was characterized as typical (solitary sessile or pedunculated) or atypical (all other descriptions).Results: A total of 110 IBD + adenoma patients, 123 IBD-nonadenoma patients, and 179 nonIBD + adenoma patients were included. Mean duration of follow-up was 88 months (SD +/- 41). The 5-year cumulative risks of AN were 11%, 3%, and 5% in IBD + adenoma, IBD-nonadenoma, and nonIBD + adenoma patients, respectively (P Conclusions: IBD patients with a histological diagnosis of adenoma have a higher risk of developing AN than adenoma patients without IBD and IBD patients without adenomas. The presence of atypical adenomas in particular was associated with this increased risk, although patients with typical adenomas were found to carry an additional risk as well. (Inflamm Bowel Dis 2013; 19: 342-349)
Databáze: OpenAIRE